New analysis: Psychedelics may be no better than SSRIs in treating depression, Kentucky ibogaine bill and New Mexico psilocybin equity fund
Plus: Bretisilocin becomes first psychedelic to receive EU priority medicines, Psychedelic Medicine Association's accreditation program and Oregon palliative psilocybin lawsuit inching forward
External link. We are not responsible for the content.
Read more ↗More From The Microdose (Berkeley)
From “just say no” to just say nothing: 5 Questions for harm reduction educator Rhana Hashemi
Hashemi discusses her approach to drug education and what students want to know about psychedelics.
A lost peyote document from 1619: 5 Questions for philosopher Osiris Sinuhé González Romero
Romero discusses what a recently discovered manuscript reveals about peyote in the 17th century.
Do people hear voices when they take ayahuasca? 5 Questions with social anthropologist David Dupuis
Dupuis discusses how auditory hallucinations during psychedelic trips have been overlooked.
Latest News
The Psychedelic Red Flags I Never Ignore
This Week's Sunday Insider: The warning signs I never ignore.
The Personalities Psychedelics Reward (And Punish)
Welcome to The Psychedelic Blog.
So, the Medicine Introduced You to Your Soulmate. Now What?
Meeting your soulmate in ceremony was the mystical part, but how do you make it last afterwards? [...] Read More... T...
Is Getting High Off of Banana Peels a Thing?
Congress really did try to regulate banana peels. [...] Read More... The post Is Getting High Off of Banana Peels a T...
Hashish Adventures in the Sixties
Review of Pipe Dreams and Smoke Screens (2025) by Richard Halford
FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.
For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies develo...